Wolverine Stack

What the Wolverine Stack covers

The Wolverine Stack is the most requested repair-research configuration we assemble: BPC-157 for connective tissue and epithelial repair signalling, TB-500 for actin sequestration and cell migration, and GHK-Cu as a copper-binding tripeptide studied in extracellular matrix remodeling, collagen synthesis and dermal research.

The three sequences act on different stages of the repair cascade — early signalling, cell mobilisation and matrix deposition — which is why they are so often examined as a set rather than in isolation. The 10 mg BPC-157 and TB-500 vials and the 50 mg GHK-Cu vial give a working quantity sufficient for an extended replicate series.

• BPC-157 10 mg — repair signalling reference sequence
• TB-500 10 mg — actin regulation and cell migration
• GHK-Cu 50 mg — copper tripeptide, matrix remodeling and dermal research

Working with a copper-bound tripeptide

GHK-Cu is a coordination complex rather than a simple peptide: the copper(II) ion is integral to the molecule and gives the reconstituted solution its characteristic blue tint. That colour is expected and is not a sign of contamination. Because free copper interferes with some colorimetric and fluorescence assays, laboratories running those readouts frequently prefer the copper-free configuration of this kit.

Avoid chelating buffers and strongly reducing conditions when handling GHK-Cu, and keep the reconstituted solution protected from prolonged light exposure. Where a protocol calls for quantitative work, calculate against net peptide content rather than the labelled gross vial weight.

Why lot matching matters in a multi-compound kit

When several sequences are studied in the same experimental series, each additional lot introduces its own purity figure, its own salt content and its own residual solvent profile. Those small differences compound: an unexplained shift in a downstream readout can come from the biology under study or simply from a different production batch entering the series mid-way.

PrimeGen kits are assembled from vials released in the same window, so the analytical baseline is fixed for the whole set. That makes the certificate data directly comparable across the kit and lets a laboratory attribute variance to the variables it actually intended to test.

Handling, storage and analytical documentation

Every vial in a PrimeGen kit ships as a lyophilized powder cake in a crimped, stoppered vial. Sealed vials are held at -20 °C, desiccated and shielded from light. Lyophilized material is ambient-stable across normal transit windows, so a kit that arrives at room temperature has not been compromised — move it to freezer storage on receipt and record the date.

Reconstitute against the vial wall with bacteriostatic or sterile diluent, swirl rather than shake, and hold reconstituted solution at 2–8 °C for a short working window. Mechanical shear, foaming and repeated freeze-thaw cycling are the three most common avoidable causes of drift between replicate runs.

Each lot in a kit is assayed in house by RP-HPLC and re-tested by an independent laboratory using HPLC and mass spectrometry. Purity is reported as area percent at the primary peak; identity is confirmed by observed mass against theoretical mass. Lot-matched certificates are published digitally and are not enclosed with the shipment.

Research use only

This kit is supplied strictly as a set of laboratory research chemicals for in vitro experimentation and analytical method development by qualified professionals. It is not a drug, dietary supplement, food or cosmetic, it has not been evaluated by any regulatory authority for safety or efficacy, and it must not be administered to humans or animals.

PrimeGen Co. is a United States distributor, not the manufacturer. Material is sourced from contract synthesis partners and released only after independent third-party verification of the specific lot supplied.